Sold as Trecator. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 1 application for Ethionamide (sold as Trecator), first approved Apr 30, 1965, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Apr 30, 1965 | TrecatorNDA 13026 ยท New molecular entity | Wyeth Pharms | 24 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
